Literature DB >> 22174260

Integrative network analysis to identify aberrant pathway networks in ovarian cancer.

Li Chen1, Jianhua Xuan, Jinghua Gu, Yue Wang, Zhen Zhang, Tian-Li Wang, Ie-Ming Shih.   

Abstract

Ovarian cancer is often called the 'silent killer' since it is difficult to have early detection and prognosis. Understanding the biological mechanism related to ovarian cancer becomes extremely important for the purpose of treatment. We propose an integrative framework to identify pathway related networks based on large-scale TCGA copy number data and gene expression profiles. The integrative approach first detects highly conserved copy number altered genes and regards them as seed genes, and then applies a network-based method to identify subnetworks that can differentiate gene expression patterns between different phenotypes of ovarian cancer patients. The identified subnetworks are further validated on an independent gene expression data set using a network-based classification method. The experimental results show that our approach can not only achieve good prediction performance across different data sets but also identify biological meaningful subnetworks involved in many signaling pathways related to ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22174260      PMCID: PMC3608394     

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  26 in total

1.  Discovering regulatory and signalling circuits in molecular interaction networks.

Authors:  Trey Ideker; Owen Ozier; Benno Schwikowski; Andrew F Siegel
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

2.  An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Authors:  Xiaojun Zhao; Cheng Li; J Guillermo Paez; Koei Chin; Pasi A Jänne; Tzu-Hsiu Chen; Luc Girard; John Minna; David Christiani; Chris Leo; Joe W Gray; William R Sellers; Matthew Meyerson
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 4.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

5.  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

Authors:  R Clarke; N Brünner; B S Katzenellenbogen; E W Thompson; M J Norman; C Koppi; S Paik; M E Lippman; R B Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.

Authors:  Jung-Hye Choi; Joon T Park; Ben Davidson; Patrice J Morin; Ie-Ming Shih; Tian-Li Wang
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

7.  Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.

Authors:  Janneta Tcherkassova; Carolina Abramovich; Rafael Moro; Chen Chen; Ralph Schmit; Angela Gerber; Ricardo Moro
Journal:  Tumour Biol       Date:  2011-05-28

8.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

9.  Human protein reference database--2006 update.

Authors:  Gopa R Mishra; M Suresh; K Kumaran; N Kannabiran; Shubha Suresh; P Bala; K Shivakumar; N Anuradha; Raghunath Reddy; T Madhan Raghavan; Shalini Menon; G Hanumanthu; Malvika Gupta; Sapna Upendran; Shweta Gupta; M Mahesh; Bincy Jacob; Pinky Mathew; Pritam Chatterjee; K S Arun; Salil Sharma; K N Chandrika; Nandan Deshpande; Kshitish Palvankar; R Raghavnath; R Krishnakanth; Hiren Karathia; B Rekha; Rashmi Nayak; G Vishnupriya; H G Mohan Kumar; M Nagini; G S Sameer Kumar; Rojan Jose; P Deepthi; S Sujatha Mohan; T K B Gandhi; H C Harsha; Krishna S Deshpande; Malabika Sarker; T S Keshava Prasad; Akhilesh Pandey
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.

Authors:  P de Graeff; A P G Crijns; K A Ten Hoor; H G Klip; H Hollema; K Oien; J M Bartlett; G B A Wisman; G H de Bock; E G E de Vries; S de Jong; A G J van der Zee
Journal:  Br J Cancer       Date:  2008-07-22       Impact factor: 7.640

View more
  6 in total

1.  Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics.

Authors:  Robert Hoehndorf; Michel Dumontier; Georgios V Gkoutos
Journal:  Bioinformatics       Date:  2012-06-17       Impact factor: 6.937

2.  An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case.

Authors:  Anup Mammen Oommen; Stephen Cunningham; Páraic S O'Súilleabháin; Brian M Hughes; Lokesh Joshi
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

3.  Identifying protein interaction subnetworks by a bagging Markov random field-based method.

Authors:  Li Chen; Jianhua Xuan; Rebecca B Riggins; Yue Wang; Robert Clarke
Journal:  Nucleic Acids Res       Date:  2012-11-17       Impact factor: 16.971

4.  Integrative network analysis of TCGA data for ovarian cancer.

Authors:  Qingyang Zhang; Joanna E Burdette; Ji-Ping Wang
Journal:  BMC Syst Biol       Date:  2014-12-31

5.  Machine learning analysis of TCGA cancer data.

Authors:  Jose Liñares-Blanco; Alejandro Pazos; Carlos Fernandez-Lozano
Journal:  PeerJ Comput Sci       Date:  2021-07-12

6.  NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis.

Authors:  Changxian Chen; Yanling Hu; Li Li
Journal:  Mol Med Rep       Date:  2015-11-11       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.